(Science: chemical) a stable synthetic analog of epoprostenol but with a longer half-life than the parent compound. The drug has vasodilator and antiplatelet activities and improves the fibrinolytic activity in patients with atherosclerotic disease, thereby providing them with further antithrombotic protection. It is also used in the treatment of raynauds disease and provides dose-dependent protection of the heart against some of the deleterious effects of ischemia and reperfusion.

Pharmacological action: platelet aggregation inhibitors, vasodilator agents.

chemical name: pentanoic acid, 5-(hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octen-6-ynyl)-2(1H)-pentalenylidene)-

Please contribute to this project, if you have more information about this term feel free to edit this page

This page was last modified on 3 October 2005, at 21:16. This page has been accessed 1,162 times. 
What links here | Related changes | Permanent link